https://european-biotechnology.com/wp-content/uploads/2024/04/_c__TeiturTrophics_foto_team_web-1024x576.jpg5761024Margarita Milidakis/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMargarita Milidakis2023-03-14 15:40:002024-04-04 16:44:29Neurodegenerative disorders are being fought with €28m
https://european-biotechnology.com/wp-content/uploads/2024/04/_c__Aymanejed_pixabay.com.jpg480720Margarita Milidakis/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMargarita Milidakis2023-03-14 13:12:122024-07-12 12:31:14Pfizer-Seagen: Acquisition in the works
Paris-based AI-inspired drug discovery specialist Iktos SA has closed a €15.5m financing to expand its platform and kick-start the new CRO Iktos Robotics.
https://european-biotechnology.com/wp-content/uploads/2024/04/money-g20fa43c82_1280.jpeg8531280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-03-09 13:18:132024-07-12 12:32:43Iktos SA raises €15.5m in Series A financing
https://european-biotechnology.com/wp-content/uploads/2024/04/_c__PublicDomainPictures_2pixabay.com.jpg640960Margarita Milidakis/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMargarita Milidakis2023-03-09 11:38:122024-10-08 09:42:12Collaboration to fight cancer
https://european-biotechnology.com/wp-content/uploads/2024/04/_c__gerald_pixabay.com22.jpg640960Margarita Milidakis/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMargarita Milidakis2023-03-08 16:28:002024-07-12 13:00:58Noema Pharma AG closes Series B financing
The Supervisory Board of Bayer AG has appointed Roche Pharmaceuticals CEO Bill Anderson (56) as new Chairman of the Management Board of Bayer AG with effect from 1 June 2023.
https://european-biotechnology.com/wp-content/uploads/2024/04/EB.com_Bill_Anderson_new_Bayer_CEO_kl..jpg940936Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-03-07 12:13:002024-07-16 17:15:50Bayer AG presents successor für CEO Baumann
https://european-biotechnology.com/wp-content/uploads/2024/04/_c__gerald_pixabay.2com.jpg643960Margarita Milidakis/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMargarita Milidakis2023-03-02 16:33:012024-07-12 12:58:27Money for AI-powered drug discovery
Drug developer Confo Therapeutics and Eli Lilly & Company have inked a worldwide licensing agreement to co develop Confo’s neurophatic pain candidate CFTX-1554.
There is increasing interest in delivering a range of drugs via inhalation because of the benefits it can offer patients. Lonzas Kim Shepard looks at the advantages of pulmonary delivery, and the prospect for inhaled biologics.
https://european-biotechnology.com/wp-content/uploads/2024/04/Kimberley_Shepard_2021_adjusted_extended-2.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-03-01 16:37:352024-04-02 15:34:24Inhalation: the potential for faster onset and fewer side-effects
Neurodegenerative disorders are being fought with €28m
Latest NewsDanish Teitur Trophics ApS announced the completion of a €28m Series A funding to progress drugs against several neurodegenerative diseases.
Pfizer-Seagen: Acquisition in the works
Latest NewsPfizer strengthens its oncology portfolio by acquiring Seagen, the biotech specialist in antibody-drug conjugates technology.
Iktos SA raises €15.5m in Series A financing
Latest NewsParis-based AI-inspired drug discovery specialist Iktos SA has closed a €15.5m financing to expand its platform and kick-start the new CRO Iktos Robotics.
Collaboration to fight cancer
Latest NewsThe charity Cancer Research UK and UCB SA collaborate on the development of two potential cures for cancer.
Noema Pharma AG closes Series B financing
Latest NewsNoema Pharma AG receives €104m in oversubscribed Series B financing round to advance its central nervous system pipeline.
Bayer AG presents successor für CEO Baumann
AppointmentsThe Supervisory Board of Bayer AG has appointed Roche Pharmaceuticals CEO Bill Anderson (56) as new Chairman of the Management Board of Bayer AG with effect from 1 June 2023.
Oculis lists at Nasdaq through SPAC merger
Latest NewsThe eye disease specialist Oculis Holding AG has been listed on Nasdaq following the merger of Oculis SA with European Biotech Acquisition Corp.
Money for AI-powered drug discovery
Latest NewsAntiverse Ltd.s AI identified eight antibodies with therapeutic potential for humans and raised €2.8m in funding for continued in-house development.
Confo Therapeutics and Lilly partner to advance CFTX-1554
Latest NewsDrug developer Confo Therapeutics and Eli Lilly & Company have inked a worldwide licensing agreement to co develop Confo’s neurophatic pain candidate CFTX-1554.
Inhalation: the potential for faster onset and fewer side-effects
Sponsored PublicationsThere is increasing interest in delivering a range of drugs via inhalation because of the benefits it can offer patients. Lonzas Kim Shepard looks at the advantages of pulmonary delivery, and the prospect for inhaled biologics.